Global Coronary Artery Bypass Grafts Market Size, Share, Trends & Growth Analysis Report 2026-2034

Description

The Coronary Artery Bypass Grafts Market size is expected to reach USD 29.26 Billion in 2034 from USD 12.37 Billion (2025) growing at a CAGR of 10.04% during 2026-2034.

The global coronary artery bypass grafts market has grown due to the increasing prevalence of cardiovascular diseases worldwide. Coronary artery bypass graft surgery is a medical procedure used to improve blood flow to the heart by bypassing blocked or narrowed arteries. This treatment is often recommended for patients with severe coronary artery disease to reduce the risk of heart attacks and improve overall heart function.

Several factors are driving the growth of this market. Aging populations and lifestyle-related health conditions such as obesity and high cholesterol are increasing the incidence of heart disease. Advances in surgical techniques and medical technologies have improved the safety and effectiveness of bypass procedures. Additionally, improved diagnostic capabilities allow earlier detection of cardiovascular problems.

In the future, the coronary artery bypass grafts market is expected to grow as healthcare systems continue to address the global burden of cardiovascular diseases. Innovations in surgical materials and techniques will improve patient outcomes and recovery times. Increasing healthcare investments and growing awareness of heart health will further support market expansion.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Method

Off-Pump
On-Pump
Minimally Invasive Direct

By Surgical Procedure

Single CABG Surgery
Double CABG Surgery
Triple CABG Surgery
Quadruple CABG Surgery

By End Use

Hospitals
Cardiology Centres
Others

COMPANIES PROFILED

Medtronic plc, Terumo Corporation, Guidant Group, MAQUET Holding BV CoKG, Novadaq Technologies Inc, KARL STORZ GmbH Co KG, Edwards Lifesciences Corporation, Genesee Biomedical Inc, Sorin Group
We can customise the report as per your requirements.

Product Code: VMR11211909

Chapter 1. PREFACE

1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

2.1. Market Snapshot
2.2. Segmental Outlook
2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

3.1. Market Lineage Outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Value Chain Analysis
3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
3.6. Porter's Five Forces Analysis
3.7. PESTLE Analysis

Chapter 4. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET: BY METHOD 2022-2034 (USD MN)

4.1. Market Analysis, Insights and Forecast Method
4.2. Off-Pump Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.3. On-Pump Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.4. Minimally Invasive Direct Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET: BY SURGICAL PROCEDURE 2022-2034 (USD MN)

5.1. Market Analysis, Insights and Forecast Surgical Procedure
5.2. Single CABG Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.3. Double CABG Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.4. Triple CABG Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.5. Quadruple CABG Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET: BY END USE 2022-2034 (USD MN)

6.1. Market Analysis, Insights and Forecast End Use
6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.3. Cardiology Centres Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET: BY REGION 2022-2034(USD MN)

7.1. Regional Outlook
7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.2.1 By Method
- 7.2.2 By Surgical Procedure
- 7.2.3 By End Use
- 7.2.4 United States
- 7.2.5 Canada
- 7.2.6 Mexico
7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.3.1 By Method
- 7.3.2 By Surgical Procedure
- 7.3.3 By End Use
- 7.3.4 United Kingdom
- 7.3.5 France
- 7.3.6 Germany
- 7.3.7 Italy
- 7.3.8 Russia
- 7.3.9 Rest Of Europe
7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.4.1 By Method
- 7.4.2 By Surgical Procedure
- 7.4.3 By End Use
- 7.4.4 India
- 7.4.5 Japan
- 7.4.6 South Korea
- 7.4.7 Australia
- 7.4.8 South East Asia
- 7.4.9 Rest Of Asia Pacific
7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.5.1 By Method
- 7.5.2 By Surgical Procedure
- 7.5.3 By End Use
- 7.5.4 Brazil
- 7.5.5 Argentina
- 7.5.6 Peru
- 7.5.7 Chile
- 7.5.8 South East Asia
- 7.5.9 Rest of Latin America
7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.6.1 By Method
- 7.6.2 By Surgical Procedure
- 7.6.3 By End Use
- 7.6.4 Saudi Arabia
- 7.6.5 UAE
- 7.6.6 Israel
- 7.6.7 South Africa
- 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

8.1. Recent Developments
8.2. Company Categorization
8.3. Supply Chain & Channel Partners (based on availability)
8.4. Market Share & Positioning Analysis (based on availability)
8.5. Vendor Landscape (based on availability)
8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL CORONARY ARTERY BYPASS GRAFTS INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Company Profiles
- 9.2.1 Medtronic Plc
- 9.2.2 Terumo Corporation
- 9.2.3 Guidant Group
- 9.2.4 MAQUET Holding B.V. & Co.KG
- 9.2.5 Novadaq Technologies Inc
- 9.2.6 KARL STORZ GmbH & Co. KG
- 9.2.7 Edwards Lifesciences Corporation
- 9.2.8 Genesee Biomedical Inc
- 9.2.9 Sorin Group